Trigeminal nerve ablation, a minimally invasive procedure, uses RF energy to destroy abnormal tissue and relieve severe, ...

FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical ...

Ronald W. McClurg, CFO, said, "product revenue increased 105% to $1.7 million" and cited "sizable improvements year-over-year ...

FDA clearance of the OneRF device for trigeminal neuralgia marks the company’s first expansion into the treatment of chronic pain. NeuroOne also sells its FDA-cleared OneRF sEEG brain ablation system ...

NeuroOne Medical Technologies Corporation NMTC recently received FDA 510(k) clearance for its OneRF Trigeminal Nerve Ablation ...

OneRF ™ Ablation System: Continued limited commercial launch of the OneRF ™ Ablation System, including first shipments, implants and ablations with OneRF ™ Ablation System ...

"NeuroOne’s nerve ablation system secures FDA clearance" was originally created and published by Medical Device Network, a ...

The OneRF ™ Ablation System is NeuroOne’s first device with a therapeutic indication and its third FDA 510 (k)-cleared device.

The OneRF Ablation System is the Company’s first device with a therapeutic indication and its third FDA 510 (k)-cleared device.

The OneRF™ Ablation System is NeuroOne’s first device with a therapeutic indication and its third FDA 510 (k)-cleared device. NeuroOne now boasts a full line of thin film electrode technology ...

NeuroOne® OneRF® Technology Success Story Featured on Fox News Provided by GlobeNewswire Apr 14, 2025 6:00am ...